
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BioVie (NASDAQ:BIVIW) through any online brokerage.
Other companies in BioVie’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for BioVie to provide a consensus price target.
The stock price for BioVie (NASDAQ: BIVIW) is $0.32 last updated September 17, 2026 at 7:56 AM EDT.
There are no upcoming dividends for BioVie.
BioVie does not have any upcoming earnings scheduled.
There is no upcoming split for BioVie.
BioVie is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BioVie Inc is a clinical-stage company developing drug therapies for the treatment of neurological and neurodegenerative disorders and liver disease. Its therapeutic areas include Alzheimer's, Parkinson's, Long COVID, Ascites, Longevity, and...